Drug General Information
Drug ID
D08MHD
Former ID
DIB002510
Drug Name
E-2609
Synonyms
Beta secretase inhibitor (Alzheimer's disease), Eisai
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 2 [525035]
Company
Eisai Co Ltd
Structure
Download
2D MOL

3D MOL

Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [544424]
References
Ref 525035ClinicalTrials.gov (NCT02322021) Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild Dementia Due to Alzheimer's Disease. U.S. National Institutes of Health.
Ref 544424Targeting the beta secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 2014 March; 13(3): 319-329.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.